EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.1 | alcohol dehydrogenase |
embryo |
- |
285626, 285632 |
1.1.1.100 | 3-oxoacyl-[acyl-carrier-protein] reductase |
embryo |
KCR1 and KCR2 |
700827 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
embryo |
dorsal blastopore lip |
697544 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
embryo |
Rdhe2 is observed starting at E12.5, increasing in abundance through E14.5. Both Rdhe2 and Rdhe2s are expressed from middle to late gestation |
-, 761505 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
embryo |
Rdhe2s is detected earlier in development at E10.5 and persisted through E14.5. Both Rdhe2 and Rdhe2s are expressed from middle to late gestation |
-, 761505 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
embryo |
the mouse embryo expresses RDH1 as early as 7.0 days post-coitus, and expression is especially intense within the neural tube, gut, and neural crest at embryo day 10.5 |
692959 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
embryo |
- |
670524 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
embryo |
low enzyme expression level |
669380 |
1.1.1.145 | 3beta-hydroxy-DELTA5-steroid dehydrogenase |
embryo |
3betaHSD VI |
389384 |
1.1.1.188 | prostaglandin-F synthase |
embryo |
- |
661605 |
1.1.1.21 | aldose reductase |
embryo |
- |
688505 |
1.1.1.211 | long-chain-3-hydroxyacyl-CoA dehydrogenase |
embryo |
- |
670476 |
1.1.1.22 | UDP-glucose 6-dehydrogenase |
embryo |
silencing of UGDH decreases glycosaminoglycan synthesis causing severe embryonic malformations because of defective gastrulation process. Overexpression of the enzyme from Xenopus laevis in human smooth muscle cells increases the accumulation of hyaluronan |
669522 |
1.1.1.267 | 1-deoxy-D-xylulose-5-phosphate reductoisomerase |
embryo |
root |
676736 |
1.1.1.27 | L-lactate dehydrogenase |
embryo |
- |
286462 |
1.1.1.270 | 3beta-hydroxysteroid 3-dehydrogenase |
embryo |
- |
286474 |
1.1.1.270 | 3beta-hydroxysteroid 3-dehydrogenase |
embryo |
high expression levels in the ganglion of the trigeminal nerve and the dorsal root ganglia |
656795 |
1.1.1.277 | 3beta-hydroxy-5beta-steroid dehydrogenase |
embryo |
somatic embryo and proembryogenic mass |
389563 |
1.1.1.284 | S-(hydroxymethyl)glutathione dehydrogenase |
embryo |
- |
697214, 762890 |
1.1.1.294 | chlorophyll(ide) b reductase |
embryo |
expression of NYC1 during embryo development and regulation, semiquantitative reverse transcription-PCR analysis, overview |
726228 |
1.1.1.30 | 3-hydroxybutyrate dehydrogenase |
embryo |
- |
739558 |
1.1.1.300 | NADP-retinol dehydrogenase |
embryo |
at different stages |
760957 |
1.1.1.300 | NADP-retinol dehydrogenase |
embryo |
RRD mRNA expression is initiated on embryo day 7 |
690876 |
1.1.1.330 | very-long-chain 3-oxoacyl-CoA reductase |
embryo |
developing embryo |
700827 |
1.1.1.35 | 3-hydroxyacyl-CoA dehydrogenase |
embryo |
KCR1 and KCR2 transcripts |
700827 |
1.1.1.36 | acetoacetyl-CoA reductase |
embryo |
developing, KCR1 and KCR2 |
700827 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
embryo |
- |
657017, 700772 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
embryo |
activity is detected in the central vasculature of the siliques |
670594 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
embryo |
activity is detected in the embryo at all developmental stages, including the seed attachment point and the integuments, NADP-ME4 |
670594 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
embryo |
at the globular and heart stage, detected in the funiculus and vascular tissue of the siliques, NADP-ME2 |
670594 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
embryo |
expression of NADP-ME1 from the torpedo stage onward |
670594 |
1.1.1.40 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) |
embryo |
hepatocytes and fibroblasts |
286743 |
1.1.1.42 | isocitrate dehydrogenase (NADP+) |
embryo |
- |
741193 |
1.1.1.43 | phosphogluconate 2-dehydrogenase |
embryo |
- |
286823 |
1.1.1.44 | phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) |
embryo |
- |
286864 |
1.1.1.44 | phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) |
embryo |
low enzyme expression level |
656766 |
1.1.1.50 | 3alpha-hydroxysteroid 3-dehydrogenase (Si-specific) |
embryo |
preembryonic mass |
-, 389563 |
1.1.1.50 | 3alpha-hydroxysteroid 3-dehydrogenase (Si-specific) |
embryo |
somatic, dark-grown |
-, 389563 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
embryo |
enzyme expression during embryogenesis from sphere to 84 h post-fertilization |
669905 |
1.1.1.53 | 3alpha(or 20beta)-hydroxysteroid dehydrogenase |
embryo |
th enzyme is expressed throughout the whole embryonic development |
763470 |
1.1.1.64 | testosterone 17beta-dehydrogenase (NADP+) |
embryo |
during embryogenesis the enzyme is present from the sphere stage until hatching |
669905 |
1.1.1.95 | phosphoglycerate dehydrogenase |
embryo |
- |
739293 |
1.1.3.15 | (S)-2-hydroxy-acid oxidase |
embryo |
expression level is similar to ubiquitin |
763602 |
1.1.3.8 | L-gulonolactone oxidase |
embryo |
- |
725858 |
1.11.1.11 | L-ascorbate peroxidase |
embryo |
- |
713234 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
embryo |
- |
696435 |
1.11.1.6 | catalase |
embryo |
zygotic |
676644 |
1.11.1.7 | peroxidase |
embryo |
- |
698048 |
1.11.1.7 | peroxidase |
embryo |
decrease in soluble peroxidase activity in embryonic calli at the time at which the somatic embryos begin to appear |
743166 |
1.11.1.9 | glutathione peroxidase |
embryo |
- |
743785 |
1.11.1.9 | glutathione peroxidase |
embryo |
extremely highly expressed in early embryos |
725049 |
1.13.11.26 | peptide-tryptophan 2,3-dioxygenase |
embryo |
- |
439520 |
1.13.11.31 | arachidonate 12-lipoxygenase |
embryo |
- |
395423 |
1.13.11.5 | homogentisate 1,2-dioxygenase |
embryo |
liver from a 20 week old male embryo |
439390 |
1.13.11.51 | 9-cis-epoxycarotenoid dioxygenase |
embryo |
- |
660396, 676502, 764795 |
1.13.11.51 | 9-cis-epoxycarotenoid dioxygenase |
embryo |
lowest expression |
765616 |
1.13.11.52 | indoleamine 2,3-dioxygenase |
embryo |
- |
659803 |
1.13.11.63 | beta-carotene 15,15'-dioxygenase |
embryo |
- |
-, 713952, 744160 |
1.13.11.63 | beta-carotene 15,15'-dioxygenase |
embryo |
mRNA is abundant at embryonic day 7, with lower expression at embryonic days 11, 13 and 15 |
438231 |
1.13.11.71 | carotenoid-9',10'-cleaving dioxygenase |
embryo |
- |
-, 744160 |
1.13.11.71 | carotenoid-9',10'-cleaving dioxygenase |
embryo |
bcdo2 is expressed in the developing zebrafish |
727353 |
1.14.11.13 | gibberellin 2beta-dioxygenase |
embryo |
embryonic axes |
439270 |
1.14.11.15 | gibberellin 3beta-dioxygenase |
embryo |
- |
676505, 676701 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
embryo |
- |
439149, 439179, 439183, 439184, 439185, 439186, 439189, 439190, 439191, 439192, 439193, 439194, 439195, 439196, 439197, 439199, 439200, 439204, 439205, 439206, 439207, 439209, 439210, 439212, 439215, 439224, 439225, 439228, 439230, 439235, 439237, 439242 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
embryo |
in embryonic development, isoform PHD45 expression is complementary to that of PHD28. Hypoxia-inducible factor HIF-1alpha protein level is maximal around stage 20 when expression of PHD45 disappears, while expression of PHD28 reaches a maximum at stage 20. Overexpression of the ubiquitin ligase Seven-in-Absentia homolog Siah2 decreases PHD45, but not PHD28, and causes the small-eye phenotype of Xenopus |
684836 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
embryo |
leg |
439188, 439247 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
embryo |
tendon cell, cartilage, skin, spleen |
439148 |
1.14.11.27 | [histone H3]-dimethyl-L-lysine36 demethylase |
embryo |
- |
724815 |
1.14.11.28 | proline 3-hydroxylase |
embryo |
- |
665517 |
1.14.11.29 | hypoxia-inducible factor-proline dioxygenase |
embryo |
detected only in the initial stages of embryo development |
741826 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
embryo |
- |
349014, 439148, 439149, 439150, 439151, 439152, 439153, 439154, 439156, 439158, 439159, 439160, 439162, 439163, 675017, 675766, 675767, 746479 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
embryo |
homogenates and cartilage |
439157 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
embryo |
tendons and sterna |
439150 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
embryo |
tissue expression profiles of the three isozymes are different, quantitative expression analysis, in situ localizations, overview |
724792 |
1.14.11.51 | DNA N6-methyladenine demethylase |
embryo |
- |
738025 |
1.14.11.65 | [histone H3]-dimethyl-L-lysine9 demethylase |
embryo |
- |
753386 |
1.14.11.66 | [histone H3]-trimethyl-L-lysine9 demethylase |
embryo |
neural folds |
753371 |
1.14.11.67 | [histone H3]-trimethyl-L-lysine4 demethylase |
embryo |
- |
700164, 744762, 764719 |
1.14.11.68 | [histone H3]-trimethyl-L-lysine27 demethylase |
embryo |
- |
755060 |
1.14.11.68 | [histone H3]-trimethyl-L-lysine27 demethylase |
embryo |
at the blastula stage, Jmjd3, Utx and H3K27 methylase Ezh2 show similar expression patterns in the animal cap and marginal zone that give rise to the ectoderm and mesoderm, respectively. The three genes maintain similar expresxadsion patterns in the neural plate, preplacodal ectoderm and axial mesoderm during the gastrula and neurula stages. Later, expression is maintained in the developing brain and cranial sensory tissues, such as the eye and ear, of tailbud embryos |
753885 |
1.14.11.69 | [histone H3]-trimethyl-L-lysine36 demethylase |
embryo |
embryonic fibroblast |
755480 |
1.14.11.69 | [histone H3]-trimethyl-L-lysine36 demethylase |
embryo |
neural folds |
753371 |
1.14.11.7 | procollagen-proline 3-dioxygenase |
embryo |
- |
349014, 439129, 698909, 746295 |
1.14.14.107 | ent-kaurenoic acid monooxygenase |
embryo |
- |
746147 |
1.14.14.14 | aromatase |
embryo |
aromatase activity in the developing brains and gonads of embryos is comparable with measurements in oviparous reptiles. Aromatase activity in the embryonic gonads is low at embryonic stage 29-34, but increases significantly at mid-development and then remains high in late stage embryos |
745021 |
1.14.14.154 | sterol 14alpha-demethylase |
embryo |
is selectively expressed in preimplantation embryos |
706694 |
1.14.14.19 | steroid 17alpha-monooxygenase |
embryo |
- |
705396 |
1.14.14.25 | cholesterol 24-hydroxylase |
embryo |
- |
705612 |
1.14.14.86 | ent-kaurene monooxygenase |
embryo |
- |
440290 |
1.14.14.87 | 2-hydroxyisoflavanone synthase |
embryo |
and pod, highest expression level of isoform IFS2. Embryos excised from developing soybean seeds also accumulate isoflavonoids from a synthetic medium. Developing soybean embryos have an ability to synthesize isoflavonoids de novo, but transport from maternal tissues may in part contribute to the accumulation of these natural products in the seed |
746088 |
1.14.15.21 | zeaxanthin epoxidase |
embryo |
- |
700831 |
1.14.17.1 | dopamine beta-monooxygenase |
embryo |
- |
703462 |
1.14.18.1 | tyrosinase |
embryo |
- |
697540 |
1.14.18.1 | tyrosinase |
embryo |
of maize seeds |
690213 |
1.14.19.10 | icosanoyl-CoA 5-desaturase |
embryo |
the enzyme is highly expressed in mid-development embryos |
745968 |
1.14.19.13 | acyl-CoA 15-desaturase |
embryo |
- |
746012 |
1.14.19.2 | stearoyl-[acyl-carrier-protein] 9-desaturase |
embryo |
- |
438428, 744605, 744992 |
1.14.19.2 | stearoyl-[acyl-carrier-protein] 9-desaturase |
embryo |
high enzyme content |
746135 |
1.14.19.3 | acyl-CoA 6-desaturase |
embryo |
- |
727338 |
1.14.19.6 | acyl-CoA (9+3)-desaturase |
embryo |
high-level expression of CSFAD2A during embryo development |
746012 |